🇺🇸 FDA
Pipeline program

ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules

25-ExoBDNF-1

Unknown other active

Quick answer

ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules for Cognitive Functions Perceptual Disturbances is a Unknown program (other) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Cognitive Functions Perceptual Disturbances
Phase
Unknown
Modality
other
Status
active

Clinical trials